IRIDEX Corporation (NASDAQ: IRIX), stock rose more than 36% in today’s premarket trading. The share price has been wild recently as investors appear eager to pounce on simple company news or fail to deliver any news at all.
Get the hottest stocks to trade every day before the market opens 100% free. Click here now.
However, on December 22, 2020, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases posted that MicroPulse Transscleral Laser Therapy, which is performed with the Cyclo G6 Laser System and MicroPulse P3 Device, proves clinically beneficial and is included in the European Glaucoma Society’s Terminology and Guidelines for Glaucoma.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Read More
The EGS guidelines can be used to standardize practice in the European Union on glaucoma diagnosis and management. On December 12-13, 2020, the new EGS guidelines were presented at the Society’s annual meeting.
The MicroPulse TLT procedure is a non-incisional procedure that significantly lowers intraocular pressure for patients with a broad range of glaucoma types and severity. Glaucoma can be treated through this procedure in cases of primary open-angle, closed-angle, and refractory glaucoma.
The MicroPulse TLT treatment is a repeatable treatment that can be applied in front of, during, or after glaucoma procedures. Over 140,000 patients have had this treatment in top ophthalmic hospitals throughout the world.
